NRXP Stock Analysis: Buy, Sell, or Hold?
NRXP - NRX Pharmaceuticals, Inc. Common Stock
$4.05
-0.57 (-12.34%)
▼
5d:
-5.37%
30d:
+35.0%
90d:
+116.58%
HOLD
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 18, 2026
0d
Get Alerted When NRXP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called NRXP this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NRXP shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: NRXP shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.50
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.65
13.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NRXP is currently trading at $4.05, which is considered extended relative to its 30-day fair value range of $2.78 to $4.00. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.1) compared to its historical average (10.7). Remarkably, the market is currently pricing in an annual earnings decline of 8.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NRXP is in a strong uptrend. Immediate support is located at $2.86, while resistance sits at $5.05. Short-term momentum is weak, with the stock down 12.3% recently.
Market Sentiment: NRXP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $42.00 (+937.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NRXP is in a strong uptrend. Immediate support is located at $2.86, while resistance sits at $5.05. Short-term momentum is weak, with the stock down 12.3% recently.
Market Sentiment: NRXP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $42.00 (+937.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.78 -
$4.00
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding NRXP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-12.3%)
- BULLISH: Trading 937.0% below Wall St target ($42.00)
- CAUTION: 5-day price weakness (-5.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.78 -
$4.00
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.86
Resistance Level
$5.06
Current Trend
Strong Uptrend
Technical data as of
Jun 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.10
Wall Street Target
$42.00
(+937.0%)
Valuation Discount vs History
-8.7% cheaper
PE vs Historical
8.1 vs 10.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.7%
(market-implied from PE analysis)
1-Year Target
$3.70
(-9%)
2-Year Target
$3.38
(-17%)
3-Year Target
$3.08
(-24%)
3-Yr Target (if PE normalizes)
(PE: 8→11)
$4.07
(+1%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.1 to 10.7
Stabilization Target:
$5.35
(+32.1%)
PE Expansion Potential:
+32.1%
Share & Embed Analysis
Last updated: June 03, 2026 5:05 PM ET
Data refreshes hourly during market hours. Next update: 6:05 PM
Data refreshes hourly during market hours. Next update: 6:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRXP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 66 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 55 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$118 | 53 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 59 HOLD |
Advanced NRXP Option Strategies
Professional options setups generated by AI based on today's NRXP price and gamma walls.
